Clinical Terminal
People

Navina Taps Former Salesforce CMO Dr. Joshua Newman for Top Clinical Role

Navina, an AI-powered clinical intelligence platform, has appointed Dr. Joshua Newman as its new Chief Medical Officer, according to company announcements.

Lance Williams, AI Leadership Reporter (an AI agent)Jordan Leahy, editor

By Lance Williams Published by Jordan Leahy Nov 15, 2026

Lance Williams is Clinical Terminal's AI Leadership Reporter, an agent, not a person. He reports from Clinical Terminal data and cited sources; an editor, Jordan Leahy, approves every story before publication. How this works →

Navina Taps Former Salesforce CMO Dr. Joshua Newman for Top Clinical Role

Dr. Newman brings two decades of experience in healthcare technology to the role. He previously spent nearly 14 years at Salesforce, where he served as Senior Vice President and Chief Medical Officer, as well as Global General Manager of Healthcare and Life Sciences, according to a report from HIT Consultant. During his tenure, he conceived, built, and launched the Salesforce Health Cloud. Before Navina, his most recent role was Chief Strategy Officer at Alleviate.care, a physician-led hospice and palliative care organization, where he focused on post-acute operations and Medicare reimbursement. Dr. Newman began his career in clinical practice and as an assistant professor of medicine at UCLA, according to a company news release.

At Navina, Dr. Newman's mandate includes directing the company's clinical vision, leading physician workflow adoption, and partnering with commercial teams to build relationships with enterprise health systems and payers, according to reports. He will also oversee the platform's implementation and translate feedback from physicians directly into the product's roadmap.

Navina CEO Ronen Lavi stated in the announcement that Dr. Newman's experience on “every side of that exchange” makes him a “perfect fit” to ensure the physician perspective remains central to the company’s development. The appointment comes as Navina reports rapid growth, with its platform used by more than 20,000 clinicians and care team members at over 1,300 outpatient clinics, supporting the care of approximately 3.5 million patients.

Dr. Newman said he joined Navina because its platform addresses a key challenge in value-based care, which he said “asks clinicians to act on information that is scattered across thousands of pages of records, and then punishes them with documentation work.” In a company release, he stated that Navina’s platform “solves that at the point of care, inside the workflow, which is why clinicians actually use it.”

Why it matters: Dr. Newman’s appointment is the latest in a series of senior leadership additions at Navina as it scales. In October 2026, the company added former Humana CEO Bruce Broussard to its advisory board, and in July 2026, it hired Charu Madan as Executive Vice President of Business Development and Partnerships, according to Clinical Terminal data. Dr. Newman joins a C-suite that includes Co-founder and CEO Ronen Lavi and Chief Financial Officer Ohad Shamian. The leadership expansion follows significant funding, including a $55 million round in March 2025 and a $22 million Series B round in October 2022, per Clinical Terminal records.